FlandersBio on Twitter

Follow us on Twitter

Archive for February 2012 - News

Archive for February 2012 - Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

Cryo-Save carries on its stem cell education program in Bulgaria


Cryo-Save Bulgaria participated in the 5th National Conference of Obstetricians & Gynecologists from the Out-patient Setting, held on February 24-26 in Plovdiv, Bulgaria. read more

arGEN-X enters into A therapeutic antibody alliance with shire


arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody™ platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire. read more

Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases


Abbott (NYSE: ABT) and Galapagos (Euronext: GLPG) announced today that they have entered into a global collaboration to develop and commercialize an oral, next-generation JAK1 inhibitor in Phase II development with the potential to treat multiple autoimmune diseases. read more

Devgen successfully expands its hybrid pearl millet seeds portfolio in India


Devgen nv (Euronext Brussels: DEVG) today announces the successful completion of the first sales season of its first hybrid pearl millet seed adapted to all pearl millet growing areas in India. read more

Devgen starts sales of two new hybrid rice seeds in India


Devgen nv (Euronext Brussels: DEVG) today announces the successful conclusion of farmer trials in India of two new premium hybrid rice varieties. Sales of these new products start in the upcoming planting season beginning in May 2012. read more

Applied Maths realizes 14% growth in 2011


Applied Maths NV proudly reports that it has realized a growth in revenues of more than 14% in 2011. This growth is remarkable in view of the financial crisis and its negative impact on budget spending for research in particular. Applied Maths has realized a growth in all continents, including Europe and the US, the company's home markets for 20 years. read more

Ablynx announces 2011 full year results


Ablynx (Euronext Brussels: ABLX), the Belgian-based biopharmaceutical company focused on the discovery and development of Nanobodies for the treatment of serious life-threatening diseases, today announced the Company's consolidated results for the year ending 31 December 2011, which have been prepared in accordance with IFRS as adopted by the European Union. read more

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top